Closing Bell
Closing Bell: Broad Sell-Off Intensifies; Netflix Gets Ready to Report Results 7/18/24
Jul 18, 2024
Market experts Joe Terranova, Brian Belski, and Alicia Levine discuss the recent stock market activity, potential correction, Netflix's upcoming results, and market rotation. Insights on market forces, economic signals, and updates on Domino's, Beyond Meat, Novartis, and Blackstone are also provided.
43:13
Episode guests
AI Summary
AI Chapters
Episode notes
Podcast summary created with Snipd AI
Quick takeaways
- Stocks show midsummer squall, potential market weather change.
- Netflix focuses on margin expansion over subscriber growth, prepares for ad business profitability.
Deep dives
Novartis Faces Questions on Growth Amid Sales Shortfall
Novartis raised its full-year earnings forecast but maintained its sales outlook after a second-quarter earnings report. Pluvicto, a drug for prostate cancer, saw sales increase over 40%, falling short of analysts' estimates. The CEO remains confident in long-term trajectory despite transitioning the drug to broader use. Novartis is actively seeking next-generation obesity drugs, focusing on cutting-edge research despite current market dynamics.
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
